Delix Therapeutics

About Delix Therapeutics

Delix Therapeutics is focused on transforming brain health treatment by harnessing neuroplastogens, a novel class of compounds. Their mission is to develop safe, fast-acting, and long-lasting therapeutics to address neuropsychiatric conditions and improve mental function through neuroplasticity.

Products & Services

Neuroplastogen-based Therapeutics:A novel class of compounds designed to induce selective neuroplasticity and rewire neural circuits to treat neuropsychiatric conditions.

Specialties

Neuroplastogens Neuroplasticity Brain Health Therapeutics Neuropsychiatric Conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 825000 MR: - FA: 825,000 FAN: 825000	D: 2024-06-04 FD: 2024-06-04	1 investors
2	RT: Grant T: - FT: Grant	A: 320000 MR: - FA: $320,000 FAN: 320000	D: 2023-12-13 FD: 2023-12-13	1 investors

Grant Latest

2024-06-04

$825K

1 investor (Pro only)

Grant 2023-12-13

$320K

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mark Rus

President & Chief Executive Officer

D

David Olson

Co-Founder, Chief Innovation Officer, Head of the SAB

D

David E. Olson

Co-Founder, Chief Innovation Officer, Head of the SAB

E

Eliseo Salinas

Head of Research and Development

A

Aaron Koenig

Chief Medical Officer

T

Tricia McCall

Chief People Officer

View 21 more team members with Pro

Unlock Full Team Directory

Recent News